Predict your next investment

Deepcell company logo
HEALTHCARE | Disease Diagnosis
deepcellbio.com

See what CB Insights has to offer

Founded Year

2017

Stage

Series A | Alive

Total Raised

$24M

Last Raised

$20M | 10 mos ago

About Deepcell

Deepcell aims to provide detailed genetic health information through ordinary blood sampling.

Deepcell Headquarter Location

1025 Terra Bella Ave Suite B

Mountain View, California, 94043,

United States

617-447-1067

Latest Deepcell News

Deepcell Partners with Stanford University on Human Cell Atlas Project

Sep 15, 2021

Save for later NEW YORK — Deepcell said on Wednesday that it has partnered with Stanford University to help build out a broadscale human cell atlas. Under the terms of the deal, Deepcell will use its AI-based technology for label-free cell isolation and collection to help Stanford generate single-cell morphology data for the Tabula Sapiens program, which aims to build a benchmark human cell atlas of 2 million cells collected from 25 organs of eight people. The work, Deepcell said, will help to create a detailed portrait of cell types, as well as a view of their distribution and variation across tissues and within the endothelial, epithelial, stromal, and immune compartments. Data from the collaboration will also be used to expand the company's Deep Cell Atlas, an atlas of single human cells that so far includes more than 1 billion cell images. The Tabula Sapiens program is run by the Chan Zuckerberg Initiative and the Chan Zuckerberg Biohub. Earlier this year, Menlo Park, California-based Deepcell began working with researchers at the University of California, Los Angeles to identify and sort cancer cells from clinical cytology samples of body fluids.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Deepcell

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Deepcell is included in 5 Expert Collections, including Genomics.

G

Genomics

823 items

Companies involved in the capture, sequencing, and/or analysis of genetic data

M

Medical Devices

7,438 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

H

Health & Wellness Assessment

2,370 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

O

Omics

1,025 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

10,319 items

Companies using/incorporating digital tech into health, wellness, and life science offerings. Includes cos operating within the hc, consumer health, and life science industries + tech vendors catering to them. Excludes cos exclusively focused on fitness/sports & performance

Deepcell Patents

Deepcell has filed 3 patents.

The 3 most popular patent topics include:

  • Aerodynamics
  • Cell biology
  • IOS games
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/15/2020

5/25/2021

IOS games, Cell biology, Machine learning, Microscopy, Aerodynamics

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/15/2020

00/00/0000

00/00/0000

Grant Date

5/25/2021

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

IOS games, Cell biology, Machine learning, Microscopy, Aerodynamics

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.